Cargando…

p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1

Accumulating evidence indicates that hotspot p53 mutants have gain-of-function in promoting cell migration and tumor metastasis. However, the molecular mechanisms are not completely understood. Here, we show that a hotspot mutation, p53-R273H, promotes non-small cell lung cancer (NSCLC) cell migrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Tao, Lv, Hong, Fei, Junjie, Xie, Yajun, Lian, Daqing, Hu, Jiang, Tang, Lizhou, Shi, Xiaodong, Wang, Jianling, Zhang, Shibo, Li, Fengtian, Jiang, Xianjie, Yi, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591995/
https://www.ncbi.nlm.nih.gov/pubmed/33123278
http://dx.doi.org/10.7150/jca.44718
Descripción
Sumario:Accumulating evidence indicates that hotspot p53 mutants have gain-of-function in promoting cell migration and tumor metastasis. However, the molecular mechanisms are not completely understood. Here, we show that a hotspot mutation, p53-R273H, promotes non-small cell lung cancer (NSCLC) cell migration and upregulates the mRNA and protein expression of neuraminidase-1 (NEU1), a sialidase involved in cell proliferation, cell migration and tumorigenesis. Silencing of NEU1 leads to upregulation of integrin β4 which significantly inhibits NSCLC cell migration induced by p53-R273H. Mechanistically, p53-R273H promotes NEU1 transcription via activation of AKT signaling. Importantly, NEU1 expression is upregulated in human NSCLC samples harboring mutant p53 and is associated with poor clinical outcome. Overall, this study highlights an important role of NEU1 in p53-R273H-induced NSCLC cell migration and provides a potential target for NSCLC diagnosis and treatment.